In the first study, (ONeil.P et al, 2018) participants were subject to a 52 week randomised trial to investigate how efficient Semaglutide injections were for weight loss when compared with Liraglutide injections and a placebo
weight loss 3 minute read Updated Semaglutide is a tried and tested medication, prescribed for weight loss under the brand name Wegovy
Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases
Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health
Hair loss is not listed as a common adverse effect for most GLP-1 medications in UK product information, though tirzepatide trials reported alopecia more frequently than placebo
The Australasian College of Dermatologists, which represents around 700 specialists across Australia, told the ABC it shared "the concerns of the broader medical community about the use of MT-II"